A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

被引:21
作者
Mascarenhas, J. [1 ]
Kosiorek, H. [2 ]
Prchal, J. [3 ]
Yacoub, A. [4 ]
Berenzon, D. [5 ]
Baer, M. R. [6 ]
Ritchie, E. [7 ]
Silver, R. T. [7 ]
Kessler, C. [8 ]
Winton, E. [9 ]
Finazzi, M. C. [10 ]
Rambaldi, A. [10 ,11 ]
Vannucchi, A. M. [12 ]
Leibowitz, D. [13 ]
Rondelli, D. [14 ]
Arcasoy, M. O. [15 ]
Catchatourian, R. [16 ]
Vadakara, J. [17 ]
Rosti, V. [18 ]
Hexner, E. [19 ]
Kremyanskaya, M. [1 ]
Sandy, L. [1 ]
Tripodi, J. [20 ]
Najfeld, V. [20 ]
Farnoud, N. [21 ]
Salama, M. E. [22 ]
Weinberg, R. S. [23 ]
Rampal, R. [21 ]
Goldberg, J. D. [24 ,25 ]
Mesa, R. [26 ]
Dueck, A. C. [2 ]
Hoffman, R. [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Univ Utah, Sch Med, Div Hematol, Salt Lake City, UT USA
[4] Univ Kansas, Canc Ctr, Kansas City, KS USA
[5] Wake Forest Univ, Med Ctr, Wake Forest Hlth, Comprehens Canc Ctr, Winston Salem, NC 27101 USA
[6] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA
[7] Weill Cornell Med Coll, New York, NY USA
[8] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[9] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA
[10] Azienda Socio Sanitaria Terr Papa Giovanni XXIII, Hematol, Bergamo, Italy
[11] Univ Milan, Dept Oncol, Milan, Italy
[12] Univ Florence, AOU Careggi, Ctr Res & Innovat Myeloproliferat Neoplasms, CRIMM, Florence, Italy
[13] Palo Alto Med Fdn Sutter Hlth, Oncol Dept, Sunnyvale, CA USA
[14] Univ Illinois, Div Hematol Oncol, Chicago, IL USA
[15] Duke Univ, Sch Med, Durham, NC USA
[16] John H Stroger Jr Hosp Cook Cty Chicago, Oncol Dept, Chicago, IL USA
[17] Geisinger Med Ctr, Danville, PA 17822 USA
[18] IRCCS Policlin San Matteo Fdn, Lab Biochem Biotechnol & Adv Diag, Ctr Study Myelofibrosis, 19 Viale Golgi, I-27100 Pavia, Italy
[19] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[20] Icahn Sch Med Mt Sinai, Dept Pathol & Med, New York, NY 10029 USA
[21] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA
[22] Mayo Med Labs, Rochester, MN USA
[23] New York Blood Ctr, New York, NY 10021 USA
[24] NYU, Sch Med, Dept Populat Hlth, New York, NY USA
[25] NYU, Sch Med, Dept Environm Med, New York, NY USA
[26] UT Hlth San Antonio Canc Ctr, San Antonio, TX USA
关键词
MYELOPROLIFERATIVE NEOPLASMS;
D O I
10.1038/s41375-019-0524-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2974 / 2978
页数:5
相关论文
共 15 条
[1]  
[Anonymous], 2015, Nature, DOI [DOI 10.1038/NATURE15393, 10.1038/nature15393]
[2]   Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference [J].
Barosi, Giovanni ;
Birgegard, Gunnar ;
Finazzi, Guido ;
Griesshammer, Martin ;
Harrison, Claire ;
Hasselbalch, Hans Carl ;
Kiladjian, Jean-Jacques ;
Lengfelder, Eva ;
McMullin, Mary Frances ;
Passamonti, Francesco ;
Reilly, John T. ;
Vannucchi, Alessandro M. ;
Barbui, Tiziano .
BLOOD, 2009, 113 (20) :4829-4833
[3]   Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients [J].
De Stefano, V. ;
Vannucchi, A. M. ;
Ruggeri, M. ;
Cervantes, F. ;
Alvarez-Larran, A. ;
Iurlo, A. ;
Randi, M. L. ;
Pieri, L. ;
Rossi, E. ;
Guglielmelli, P. ;
Betti, S. ;
Elli, E. ;
Finazzi, M. C. ;
Finazzi, G. ;
Zetterberg, E. ;
Vianelli, N. ;
Gaidano, G. ;
Nichele, I. ;
Cattaneo, D. ;
Palova, M. ;
Ellis, M. H. ;
Cacciola, E. ;
Tieghi, A. ;
Hernandez-Boluda, J. C. ;
Pungolino, E. ;
Specchia, G. ;
Rapezzi, D. ;
Forcina, A. ;
Musolino, C. ;
Carobbio, A. ;
Griesshammer, M. ;
Barbui, T. .
BLOOD CANCER JOURNAL, 2016, 6 :e493-e493
[4]   Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases [J].
De Stefano, Valerio ;
Rossi, Elena ;
Carobbio, Alessandra ;
Ghirardi, Arianna ;
Betti, Silvia ;
Finazzi, Guido ;
Vannucchi, Alessandro M. ;
Barbui, Tiziano .
BLOOD CANCER JOURNAL, 2018, 8
[5]   Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment [J].
De Stefano, Valerio ;
Qi, Xingshun ;
Betti, Silvia ;
Rossi, Elena .
THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) :240-249
[6]   Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018 [J].
Finazzi, Guido ;
De Stefano, Valerio ;
Barbui, Tiziano .
BLOOD CANCER JOURNAL, 2018, 8
[7]   Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases [J].
Lavu, Sravanthi ;
Szuber, Natasha ;
Mudireddy, Mythri ;
Yogarajah, Meera ;
Gangat, Naseema ;
Pardanani, Animesh ;
Hanson, Curtis A. ;
Ketterling, Rhett P. ;
Ashrani, Aneel A. ;
Kamath, Patrick S. ;
Tefferi, Ayalew .
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (03) :E61-E64
[8]   Analysis of protein-coding genetic variation in 60,706 humans [J].
Lek, Monkol ;
Karczewski, Konrad J. ;
Minikel, Eric V. ;
Samocha, Kaitlin E. ;
Banks, Eric ;
Fennell, Timothy ;
O'Donnell-Luria, Anne H. ;
Ware, James S. ;
Hill, Andrew J. ;
Cummings, Beryl B. ;
Tukiainen, Taru ;
Birnbaum, Daniel P. ;
Kosmicki, Jack A. ;
Duncan, Laramie E. ;
Estrada, Karol ;
Zhao, Fengmei ;
Zou, James ;
Pierce-Hollman, Emma ;
Berghout, Joanne ;
Cooper, David N. ;
Deflaux, Nicole ;
DePristo, Mark ;
Do, Ron ;
Flannick, Jason ;
Fromer, Menachem ;
Gauthier, Laura ;
Goldstein, Jackie ;
Gupta, Namrata ;
Howrigan, Daniel ;
Kiezun, Adam ;
Kurki, Mitja I. ;
Moonshine, Ami Levy ;
Natarajan, Pradeep ;
Orozeo, Lorena ;
Peloso, Gina M. ;
Poplin, Ryan ;
Rivas, Manuel A. ;
Ruano-Rubio, Valentin ;
Rose, Samuel A. ;
Ruderfer, Douglas M. ;
Shakir, Khalid ;
Stenson, Peter D. ;
Stevens, Christine ;
Thomas, Brett P. ;
Tiao, Grace ;
Tusie-Luna, Maria T. ;
Weisburd, Ben ;
Won, Hong-Hee ;
Yu, Dongmei ;
Altshuler, David M. .
NATURE, 2016, 536 (7616) :285-+
[9]   Exploring single-sample SNP and INDEL calling with whole-genome de novo assembly [J].
Li, Heng .
BIOINFORMATICS, 2012, 28 (14) :1838-1844
[10]   Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials [J].
Mascarenhas, John ;
Mesa, Ruben ;
Prchal, Josef ;
Hoffman, Ronald .
HAEMATOLOGICA, 2014, 99 (06) :945-949